US Market Report for Orthopedic Hyaluronic Acid Viscosupplementation 2017 - MedCore

  • ID: 4085806
  • Report
  • Region: United States
  • 464 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

- Market Drivers & Limiters for each chapter segment

- Competitive Analysis for each chapter segment

- Section on recent mergers & acquisitions

Hyaluronic acid products involve one-, two-, three- or five-dose cycles, with the actual number of doses taken often being less than a full treatment. The growth of single-injection products over three- and five-injection products has been the most significant trend in the market. The single-injection has, to some extent, cannibalized other injection types; the convenience of the single-injection procedure has aided market penetration. The introduction of a two injection product in 2016 will further squeeze market share from the three- and five-injection products. Furthermore, viscosupplementation is beginning to be an expected treatment before joint replacement; this will drive unit sales growth.

As of 2016, both the single-injection and triple-injection markets were approximately the same in terms of market value, with the triple-injection being a little larger. While the three-injection market continues its positive growth, the collective hyaluronic acid viscosupplementation market is shifting to single-injection. The single-injection market is expected to become the largest segment of the HA market in the next couple of years because due to ease-of-use.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology And Musculoskeletal System
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication For Bone Graft Procedure
2.2.5 Indication For Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Hyaluronic Acid Viscosupplementation
3.2 Regulatory Issues And Recalls
3.2.1 Hyaluronic Acid Viscosupplementation
3.3 Clinical Trials
3.3.1 Hyaluronic Acid Viscosupplementation

4. Orthopedic Hyaluronic Acid Viscosupplementation Market
4.1 Introduction
4.1.1 Benefits Of Viscosupplementation
4.1.2 Synovial Fluid
4.1.3 Product Types
4.1.3.1 Single-Injection Products
4.1.3.2 Two-Injection Cycle Products
4.1.3.3 Three-Injection Cycle Products
4.1.3.4 Three/Five-Injection Cycle Products
4.1.4 Reimbursement
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Hyaluronic Acid Viscosupplementation Market
4.3.1.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
4.3.1.2 Three-Injection Hyaluronic Acid Viscosupplementation Market
4.3.1.3 Five-Injection Hyaluronic Acid Viscosupplementation Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

List of Charts

Chart 1 1: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
Chart 4 1: Orthopedic Hyaluronic Acid Viscosupplementation Market By Segment, U.S., 2013 - 2023
Chart 4 2: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2016
Chart 4 3: Orthopedic Hyaluronic Acid Viscosupplementation Market Breakdown, U.S., 2023
Chart 4 4: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Chart 4 5: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Chart 4 6: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Chart 4 7: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Chart 4 8: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016

List of Figures

Figure 1 1: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (1 Of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, U.S., 2016
Figure 1 4: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (1 Of 2)
Figure 1 5: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (2 Of 2)
Figure 1 6: Recent Events In The Orthopedic Biomaterials Market, U.S., 2013 - 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 Of 2)
Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 Of 2)
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 Of 3)
Figure 3 1: Hyaluronic Acid Viscosupplementationby Products By Company
Figure 3 2: Class 3 Device Recall Euflexxa (1 Sodium Hyaluronate)
Figure 3 3: Trial Comparing Botulin Toxin Versus Hyaluronic Acid By Intra-Articular Injection (Gotox)
Figure 3 4: Trial To Assess The Structural Effect And Long-Term Symptomatic Relief Of Intra-Articular Injections Of Ha (Viscoa)
Figure 3 5: Platelet-Rich Plasma Vs. Hyaluronic Acid For Glenohumeral Osteoarthritis
Figure 3 6: Comparative Assessment Of Viscosupplementation With Polynucleotides And Hyaluronic Acid (Pnha1401)
Figure 3 7: To Look At The Characteristics Of Synovial Fluid And Cartilage Matrix In Osteoarthritic Knee After Hyaluronic Acid Injection
Figure 3 8: Platelet-Rich Plasma Vs Viscosupplementation In The Treatment Of Knee Articular Degenerative Pathology (Prp)
Figure 3 9: Platelet-Rich Plasma Intra-Articular Injection In Treating Hemophilic Arthropathy
Figure 3 10: Effectiveness Of Two Hyaluronic Acids In Osteoarthritis Of The Knee
Figure 4 1: Orthopedic Hyaluronic Acid Viscosupplementation Market By Segment, U.S., 2013 - 2023 (Us$M)
Figure 4 2: Total Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Figure 4 3: Single-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Figure 4 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Figure 4 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, U.S., 2013 - 2023
Figure 4 6: Drivers And Limiters, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016
Figure 4 7: Leading Competitors, Orthopedic Hyaluronic Acid Viscosupplementation Market, U.S., 2016
Figure 6 1: Press Release Summary

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll